Intravenous ketamine for rapid treatment of major depressive disorder in the general medical hospital.
Siobhan Helen GeeCamille WrattenRuth CairnsAlastair SanthouseDavid TaylorPublished in: BMJ case reports (2021)
Major depressive disorder (MDD) is common in general medical settings, and can usually be treated with conventional oral antidepressants. For some patients, however, oral treatment is refused or not possible, and the untreated symptoms can have a significant impact on the treatment of the acute medical problem. Use of intravenous ketamine has been widely reported in mental health settings for the treatment of MDD. We describe use of intravenous ketamine in a general medical hospital for the treatment of MDD in an 83-year-old male patient who refused food, fluid and medical investigations following a stroke.
Keyphrases
- major depressive disorder
- healthcare
- bipolar disorder
- mental health
- newly diagnosed
- emergency department
- pain management
- atrial fibrillation
- end stage renal disease
- chronic kidney disease
- physical activity
- case report
- combination therapy
- depressive symptoms
- ejection fraction
- quantum dots
- smoking cessation
- mechanical ventilation
- cerebral ischemia
- sensitive detection
- respiratory failure